-
Why Nuvation Bio Shares Are Rising
Monday, December 13, 2021 - 1:01pm | 136Read More...Nuvation Bio Inc (NYSE: NUVB) shares are trading higher after the company announced FDA clearance of its investigational new drug application for NUV-422. "FDA clearance of our third IND application for NUV-422 is another important achievement for our lead investigational CDK 2/4/6 inhibitor...
-
Medivation Advises Its Shareholders To Spurn Sanofi's Move To Replace Entire Board
Wednesday, May 25, 2016 - 10:48am | 444Read More...Medivation Inc (NASDAQ: MDVN) disclosed that it advised its stockholders to reject Sanofi SA (ADR) (NYSE: SNY)'s attempt to replace its entire board of directors with hand-picked nominees through a proposed consent solicitation. The company believes it was a strategy for Sanofi to make easy its...
-
Here's What Medivation Said In Its Rejection Letter To Sanofi
Friday, April 29, 2016 - 2:38pm | 361Read More...Medivation Inc (NASDAQ: MDVN) disclosed on Friday a letter it has written to Sanofi SA (ADR) (NYSE: SNY) with regards to its acquisition offer to buy the company for $52.50 per share. Medivation started off by stating its Board of Directors unanimously rejected Sanofi's proposal to fully...
